Routine NHS care facing ‘enormous’ disruption with hospitals to lose tens of thousands of doctors for 72 hours
Strike action across England this week will significantly disrupt almost all routine care in the NHS, England’s top doctor has warned today. Professor Sir Stephen Powis said that industrial action by junior doctors, starting at 7am on Wednesday, meant thousands of routine procedures had already been postponed by trusts, as the NHS prioritises emergency and life-saving care.
NHS expands high-res skin imaging to speed up cancer diagnoses and treatment for tens of thousands of patients
Tens of thousands of patients are set to receive a diagnosis and treatment for skin cancer faster, with accelerated NHS rollout of ‘teledermatology’, which involves taking high spec images of spots, moles or lesions on people’s skin.
New NHS measures to improve eye care and cut waiting times
The NHS is publishing new clinical guidance which could reduce waiting times for eye care services for patients in England. As part of a wide-ranging list of evidence-based interventions designed to improve the quality of care, the guidance proposes patients get access to more sophisticated diagnostic imaging before they are referred to a consultant.
World Blood Cancer Day
What is blood cancer? Every 27 seconds someone somewhere in the world receives a devastating diagnosis: blood cancer. Blood cancer is the general term for malignant defects in the blood-forming system.
Record number of nurses, midwives and nursing associates
The number of professionals leaving the register fell slightly but research indicates more than half left sooner than planned and most don’t plan to return. Five compounding workforce pressures frequently influenced decisions to leave, including concerns about the quality of people’s care.
NHS rolls out new ‘lifeline’ combination therapy for hundreds of women with womb cancer
Hundreds of women with advanced womb cancer in England are to be offered a new ‘lifeline’ option from today, as the NHS rolls out a life-extending new combination therapy that can halt the progression of the disease for twice as long as chemotherapy. The NHS has agreed landmark commercial deals for two drugs from different manufacturers, which will be used in combination to treat advanced endometrial cancer in between 500 and 750 women each year.
